Why TD Cowen Calls The Cigna Group (CI) "A Best Ideas Pick" For 2026

The Cigna Group (NYSE:CI) is among the cheap healthcare stocks to buy heading into 2026. On December 5, TD Cowen reaffirmed a ‘Buy’ rating on The Cigna Group (NYSE:CI) and a price target of $333, which suggests an upside potential of 25.5%. The analyst also highlighted the company as a “Best Ideas 2026” pick.

TD Cowen highlighted that the company’s 2026 EPS will be within a specific range, while the stock trades at a decade-low valuation, implying it is “largely de-risked.” The analyst believes the company’s new rebate-free pharmacy benefit management (PBM) model will be the first step toward broader PBM reforms that could address regulatory issues and drive better valuation. What’s even more interesting is that the firm described the company’s segment guidance as “conservative,” emphasizing core earnings from the specialty pharmacy business.

Separately, on December 2, Guggenheim maintained its ‘Buy’ rating on The Cigna Group (NYSE:CI) and raised its price target to $318 from $309, according to TheFly. This revision reflects an upside potential of 20%.

The Cigna Group (NYSE:CI) is a Connecticut-based provider of insurance and related products and services. Founded in 1792, the company mainly operates through Evernorth Health Services and Cigna Healthcare segments.

While we acknowledge the potential of CI as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money.

Disclosure: None.